KMDA (Kamada Ltd.) Stock Financials & Earnings | Market Cap Arena

KMDA (Kamada Ltd.) Stock Financials & Earnings | Market Cap Arena

KMDAKamada Ltd.

Mkt Cap$520M

Healthcare·Drug Manufacturers - Specialty & Generic·🇮🇱 Israel·NASDAQ

Revenue (TTM)$175M

Net Income (TTM)$20M

EPS (TTM)$0.36

Free Cash Flow (TTM)$18M

Gross Margin43.8%

Op. Margin15.9%

Net Margin11.7%

FCF Margin10.5%

P/S Ratio (TTM)3.0x

P/E Ratio (TTM)25.4x

YoY Rev Growth+10.4%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$45M	$15M	$4M
Q1 23	$31M	$12M	$289K
Q2 23	$37M	$14M	$3M
Q3 23	$38M	$15M	$4M
Q4 23	$36M	$14M	$3M
Q1 24	$38M	$17M	$4M
Q2 24	$42M	$19M	$6M
Q3 24	$42M	$17M	$5M
Q4 24	$39M	$17M	$5M
Q1 25	$44M	$21M	$8M
Q2 25	$45M	$19M	$7M
Q3 25	$47M	$20M	$8M

Revenue Breakdown

Valuation

Quarter	P/S	P/E
Q4 22	4.0x	—
Q1 23	3.9x	—
Q2 23	3.6x	151.6x
Q3 23	3.4x	84.3x
Q4 23	3.6x	62.8x
Q1 24	3.5x	41.7x
Q2 24	3.4x	34.5x
Q3 24	3.3x	33.1x
Q4 24	3.2x	36.0x
Q1 25	3.1x	32.4x
Q2 25	3.1x	27.4x
Q3 25	3.0x	25.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	$7M	$6M
Q1 23	-$3M	-$4M
Q2 23	$2M	$770K
Q3 23	$921K	-$808K
Q4 23	$4M	$2M
Q1 24	$1M	-$2M
Q2 24	$14M	$11M
Q3 24	$22M	$20M
Q4 24	$10M	$7M
Q1 25	-$513K	-$2M
Q2 25	$8M	$6M
Q3 25	$10M	$7M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$977K
Q1 23	$1M
Q2 23	$1M
Q3 23	$2M
Q4 23	$2M
Q1 24	$3M
Q2 24	$3M
Q3 24	$2M
Q4 24	$3M
Q1 25	$1M
Q2 25	$2M
Q3 25	$4M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+44.4%	+19.1%
Q1 23	+9.3%	+9.2%
Q2 23	+58.7%	+34.5%
Q3 23	+17.7%	+13.2%
Q4 23	-19.8%	-18.7%
Q1 24	+22.9%	+10.8%
Q2 24	+13.4%	+5.8%
Q3 24	+10.0%	+8.6%
Q4 24	+7.1%	+0.8%
Q1 25	+16.6%	+7.5%
Q2 25	+5.4%	+2.3%
Q3 25	+12.6%	+7.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$218K	0.5%
Q1 23	$415K	1.4%
Q2 23	$214K	0.6%
Q3 23	$312K	0.8%
Q4 23	$373K	1.0%
Q1 24	$241K	0.6%
Q2 24	$235K	0.6%
Q3 24	$224K	0.5%
Q4 24	$174K	0.4%
Q1 25	$175K	0.4%
Q2 25	$95K	0.2%
Q3 25	$117K	0.2%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 22	$3M	$6M	—
Q1 23	$3M	$3M	$4M
Q2 23	$4M	$3M	$4M
Q3 23	$3M	$4M	$4M
Q4 23	$3M	$8M	—
Q1 24	$4M	$4M	$5M
Q2 24	$5M	$4M	$5M
Q3 24	$3M	$4M	$5M
Q4 24	$3M	$9M	—
Q1 25	$4M	$4M	$5M
Q2 25	$3M	$4M	$5M
Q3 25	$3M	$5M	$5M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$34M	$0	$34M
Q1 23	$27M	$0	$27M
Q2 23	$22M	$0	$22M
Q3 23	$53M	$0	$53M
Q4 23	$56M	$0	$56M
Q1 24	$48M	$0	$48M
Q2 24	$57M	$0	$57M
Q3 24	$72M	$0	$72M
Q4 24	$78M	$0	$78M
Q1 25	$76M	$0	$76M
Q2 25	$66M	$0	$66M
Q3 25	$72M	$0	$72M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	45M	-7.4%
Q1 23	45M	-0.0%
Q2 23	45M	+0.0%
Q3 23	54M	+19.8%
Q4 23	57M	+7.0%
Q1 24	57M	-0.0%
Q2 24	55M	-3.7%
Q3 24	55M	-0.3%
Q4 24	54M	-1.4%
Q1 25	57M	+4.1%
Q2 25	57M	+0.2%
Q3 25	59M	+3.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$244K	289
FY 14	$238K	302
FY 15	$220K	319
FY 16	$206K	377
FY 17	$249K	413
FY 18	$281K	408
FY 19	$296K	429
FY 20	$327K	408
FY 21	$290K	357
FY 22	$340K	380
FY 23	$411K	347
FY 24	$402K	400